As one of the world’s leading analytical instrumentation companies, Bruker covers a broad spectrum of advanced solutions in all fields of research and development. All systems and instruments are designed to improve safety of products, accelerate time-to-market and support industries in successfully enhancing quality of life. Bruker has been driving innovation in analytical instrumentation for 50 years now. Today, worldwide more than 6,000 employees are working on this permanent challenge, at over 70 locations on all continents.
Bruker Corporation acquired Sierra Sensors as of June 2018 to expand its real-time, label-free detection portfolio for pharma and biopharma drug discovery. Sierra Sensors, now Bruker SPR develops and manufactures innovative analytical biosensors based on Surface Plasmon Resonance (SPR) detection. Driven by patented technologies in the areas of SPR detection and microfluidic sample delivery, Sierra instruments are setting a new standard in high-throughput and high-performance label-free analysis. Bruker SPR (Sierra Sensors) began operations in 2006 with offices in Hamburg, Germany and in Rhode Island, USA. With many years of experience in the analytical biosensor industry, it has been the mission of the management team to advance real-time array SPR by integrating highest quality label-free detection with cutting-edge technologies for sample delivery, sensor design, automation and software.
The highly innovative systems of Bruker SPR (Sierra Sensors) in combination with the long-standing experience of Bruker Corporation and its sales network will add great value for scientists in life science.
The incumbent will be responsible to further develop and execute the European sales strategy for Bruker SPR. The jobholder will conduct analysis of opportunities in the target market and develop business with pharma, biotech companies and academia.